Literature DB >> 15250384

[The evidence base of clinical practice guidelines, health technology assessments and patient information as a basis for clinical decision-making].

Gerd Antes1.   

Abstract

Valid assessments of benefit and harm of health care interventions are derived from unbiased patient-based clinical trials. Bias sources may affect different study types in different ways, leading to varying validity of study results. The efficient transfer of relevant study results into medical practice is the main objective of evidence-based medicine. To archive this, systematic reviews summarising the study results with respect to a focussed question have proved a powerful tool. They can be used for decision making by individuals as well as evidence source for clinical practice guidelines, health technology assessment and patient information.

Entities:  

Mesh:

Year:  2004        PMID: 15250384

Source DB:  PubMed          Journal:  Z Arztl Fortbild Qualitatssich        ISSN: 1431-7621


  8 in total

1.  How close is evidence to truth in evidence-based treatment of mental disorders?

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-11-22       Impact factor: 5.270

Review 2.  [Problems of evidence-based medicine in psychopharmacotherapy: problems of evidence grading and of the evidence basis for complex clinical decision making].

Authors:  H-J Möller; W Maier
Journal:  Nervenarzt       Date:  2007-09       Impact factor: 1.214

3.  Evidence-based medicine in psychopharmacotherapy: possibilities, problems and limitations.

Authors:  Hans-Jürgen Möller; Wolfgang Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-02       Impact factor: 5.270

Review 4.  Is evidence sufficient for evidence-based medicine?

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-11       Impact factor: 5.270

5.  To whom do the results of the multicenter, randomized, controlled INSECT trial (ISRCTN 24023541) apply?--assessment of external validity.

Authors:  Lars Fischer; Hanns P Knaebel; Henriette Golcher; Thomas Bruckner; Markus K Diener; Jeannine Bachmann; Markus W Büchler; Christoph M Seiler
Journal:  BMC Surg       Date:  2012-02-08       Impact factor: 2.102

6.  The relationship between external and internal validity of randomized controlled trials: A sample of hypertension trials from China.

Authors:  Xin Zhang; Yuxia Wu; Pengwei Ren; Xueting Liu; Deying Kang
Journal:  Contemp Clin Trials Commun       Date:  2015-11-19

7.  The external validity of randomized controlled trials of hypertension within China: from the perspective of sample representation.

Authors:  Xin Zhang; Yuxia Wu; Deying Kang; Jialiang Wang; Qi Hong
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

8.  Representativeness of the participants in the smoking Cessation in Pregnancy Incentives Trial (CPIT): a cross-sectional study.

Authors:  Barnabas Bessing; Linda Bauld; Lesley Sinclair; Daniel F Mackay; William Spence; David M Tappin
Journal:  Trials       Date:  2016-08-26       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.